Taken together, our findings highlight the pivotal role of MKRN1-AGC1 axis in dictating CRC chemoresistance and offer novel therapeutic strategies for overcoming Oxa-resistance. The gene discussed is SLC25A12; the disease is colorectal carcinoma.